# PDT For Induction Therapy For Head And Neck Cancer

> **NCT07214987** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 26 (estimated)

## Conditions studied

- Squamous Cell Carcinoma
- Head and Neck Cancer Squamous Cell Carcinoma
- Head and Neck Cancer

## Interventions

- **DRUG:** Toripalimab-tpzi
- **DRUG:** Cisplatin
- **DRUG:** Docetaxel

## Key facts

- **NCT ID:** NCT07214987
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-09
- **Primary completion:** 2027-12-31
- **Final completion:** 2029-09-01
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2026-01-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07214987

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07214987, "PDT For Induction Therapy For Head And Neck Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07214987. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*